J05AP: Antivirals for treatment of HCV infections

Explore J05AP Antivirals for treatment of HCV infections in the ATC classification system. Part of J Antiinfectives for Systemic Use > J05 Antivirals for Sys...

🏷 ATC Code: J05AP 📊 Level: 4 💊 Ingredients: 19 ✓ WHO ATC Classification

About Antivirals for treatment of HCV infections

J05AP Antivirals for treatment of HCV infections is part of the WHO ATC classification system and belongs to J Antiinfectives for Systemic Use > J05 Antivirals for Systemic Use > J05A Direct Acting Antivirals. This chemical subgroup page helps users identify more specific classifications and related active ingredients associated with this ATC code. It also includes 19 related active ingredients, supporting deeper navigation across ingredient-level pages. Use this page to explore the ATC hierarchy, review connected groups, and find relevant ingredient pages within Pharmassive.

Active Ingredients in Antivirals for treatment of HCV infections

19 ingredients

Asunaprevir View details → Boceprevir View details → Daclatasvir View details → Daclatasvir, Asunaprevir and Beclabuvir View details → Dasabuvir View details → Dasabuvir, Ombitasvir, Paritaprevir and Ritonavir View details → Elbasvir View details → Elbasvir and Grazoprevir Standard Dose View details → Faldaprevir View details → Glecaprevir and Pibrentasvir Standard Dose View details → Grazoprevir View details → Ombitasvir, Paritaprevir and Ritonavir Standard Dose View details → Ribavirin View details → Simeprevir View details → Sofosbuvir View details → Sofosbuvir and Ledipasvir Standard Dose View details → Sofosbuvir and Velpatasvir Standard Dose View details → Sofosbuvir, Velpatasvir and Voxilaprevir Standard Dose View details → Telaprevir View details →